May

22

2024

Med anledning bolagets delårsrapport för tredje kvartalet, bjuder Hamlet BioPharma in till en livesänd digital investerarträff fredagen den 24 maj klo...

May

06

2024

Hamlet BioPharma – the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections – has success...

Apr

18

2024

Hamlet BioPharma – the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, has secured contin...

Apr

11

2024

Hamlet BioPharma – the pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections, announces today t...

Apr

03

2024

Hamlet BioPharma announced on January 25 that clinical data showed a strong immune response with anti-tumor potential in Alpha1H-treated patients with...

Mar

27

2024

Hamlet BioPharma invites you to a series of events aiming to provide insights into the project portfolio’s strong development pipeline, the advanced t...

Mar

26

2024

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, participated in Økonomisk Ugebrev’s ...

Mar

06

2024

Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, is proud to announce its participati...

Feb

22

2024

DETTA PRESSMEDDELANDE FÅR INTE OFFENTLIGGÖRAS, PUBLICERAS ELLER DISTRIBUERAS, DIREKT ELLER INDIREKT, I ELLER TILL AUSTRALIEN, BELARUS, HONGKONG, JAPAN...

Feb

22

2024

...